 |
|
Clinical Assessment of 31 Patients With Wilson's DiseaseCorrelations With Structural Changes on Magnetic Resonance Imaging
Simon Starosta-Rubinstein, MD;
Anne B. Young, MD, PhD;
Karen Kluin, MS;
Gretchen Hill, PhD;
Alex M. Aisen, MD;
Trygve Gabrielsen, MD;
George J. Brewer, MD
Arch Neurol. 1987;44(4):365-370.
Abstract
| |
• Thirty-one patients with Wilson's disease were evaluated with detailed neurologic and medical examinations. Mean age (±SD) at onset was 21 ± 5 years and at examination was 28 ± 6 years. Of the 90% of patients who were first treated with penicillamine, 31% deteriorated initially despite therapy, and half never recovered to pretherapy baseline. At the time of our evaluations, the most common neurologic findings were dysarthria (97%), dystonia (65%), dysdiadochokinesia (58%), rigidity (52%), gait and postural abnormalities (42%), and tremor (32%). Chorea and dementia were rare. Twentytwo patients underwent magnetic resonance imaging. All but one of the 19 symptomatic patients had abnormal scans. The three asymptomatic patients had normal scans. Most lesions were seen in the caudate, putamen, subcortical white matter, midbrain, and pons. Generalized brain atrophy was also common. Lesions were less common in the thalamus, cerebellar vermis, midbrain tegmentum, globus pallidus, red nucleus, and dentate nucleus. Dystonia and bradykinesia correlated with putamen lesions, and dysarthria correlated with both putamen and caudate lesions.
Author Affiliations
From the Departments of Neurology (Drs Starosta-Rubinstein and Young), Internal Medicine (Drs Brewer and Hill), Radiology (Drs Aisen and Gabrielsen), and Physical Medicine and Rehabilitation (Ms Kluin), University of Michigan, Ann Arbor.
Footnotes
Accepted for publication Jan 9, 1987.
Presented in part at the American Academy of Neurology Meetings, Dallas, May 1, 1985.
Reprint requests to Neuroscience Laboratory Building, 1103 E Huron St, Ann Arbor, MI 48104 (Dr Young).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Sequential MRI changes in Wilson's disease with de-coppering therapy: a study of 50 patients
Sinha et al.
Br. J. Radiol. 2007;80:744-749.
ABSTRACT
| FULL TEXT
CT findings in methanol intoxication
Almansori and Ahmed
CMAJ 2007;176:620-620.
FULL TEXT
Subcortical white matter abnormalities related to drug resistance in Wilson disease.
Aikath et al.
Neurology 2006;67:878-880.
ABSTRACT
| FULL TEXT
MR Imaging of the Brain in Wilson Disease of Childhood: Findings Before and After Treatment with Clinical Correlation
Kim et al.
Am. J. Neuroradiol. 2006;27:1373-1378.
ABSTRACT
| FULL TEXT
Clinical correlates of cerebral water diffusion in Wilson disease
Favrole et al.
Neurology 2006;66:384-389.
ABSTRACT
| FULL TEXT
Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease
Page et al.
Neurology 2004;63:638-643.
ABSTRACT
| FULL TEXT
Diffusion MR Imaging Changes Associated with Wilson Disease
Sener
Am. J. Neuroradiol. 2003;24:965-967.
ABSTRACT
| FULL TEXT
Development of Neurologic Symptoms in a 26-Year-Old Woman Following Recovery From Methanol Intoxication
Fontenot and Pelak
Chest 2002;122:1436-1439.
FULL TEXT
Wilson Disease
Patel and Bozdech
Arch Ophthalmol 2001;119:1556-1557.
FULL TEXT
Neuropsychiatric Correlates and Treatment of Lenticulostriatal Diseases: A Review of the Literature and Overview of Research Opportunities in Huntington's, Wilson's, and Fahr's Diseases
ANPA Committee on Research et al.
J. Neuropsychiatry Clin. Neurosi. 1998;10:249-266.
ABSTRACT
| FULL TEXT
Neuropsychiatric Aspects of the Adult Variant of Tay-Sachs Disease
MacQueen et al.
J. Neuropsychiatry Clin. Neurosi. 1998;10:10-19.
ABSTRACT
| FULL TEXT
Penicillamine-Related Neurologic Syndrome in a Child Affected by Wilson Disease With Hepatic Presentation
Porzio et al.
Arch Neurol 1997;54:1166-1168.
ABSTRACT
Wilson's Disease: Development of Neurological Disease After Beginning Penicillamine Therapy
Glass et al.
Arch Neurol 1990;47:595-596.
ABSTRACT
|
